keyword
https://read.qxmd.com/read/38704558/intracranial-residual-lesions-following-early-intensification-in-a-patient-with-t-cell-acute-lymphoblastic-leukemia-a-case-report
#1
JOURNAL ARTICLE
Yuichi Nagamatsu, Takeshi Isoda, Motoki Inaji, Jun Oyama, Daiki Niizato, Dan Tomomasa, Noriko Mitsuiki, Motoi Yamashita, Takahiro Kamiya, Kohsuke Imai, Hirokazu Kanegane, Tomohiro Morio, Masatoshi Takagi
BACKGROUND: T-cell acute lymphoblastic leukemia (T-ALL) tends to involve central nervous system (CNS) infiltration at diagnosis. However, cases of residual CNS lesions detected at the end of induction and post early intensification have not been recorded in patients with T-ALL. Also, the ratio and prognosis of patients with residual intracranial lesions have not been defined. CASE PRESENTATION: A 9-year-old boy with T-ALL had multiple intracranial tumors, which were still detected post early intensification...
May 4, 2024: BMC Pediatrics
https://read.qxmd.com/read/38704030/acute-promyelocytic-leukemia-with-torque-teno-mini-virus-ttmv-rara-fusion-an-approach-to-screening-and-diagnosis
#2
JOURNAL ARTICLE
Harrison K Tsai, Mark F Sabbagh, Meagan Montesion, Erik A Williams, Arnaldo Arbini, Daniel R Boué, Emily M Harris, Franziska Wachter, Leslie Grimmett, Andrew E Place, Fabienne Lucas, Valentina Nardi, Annette S Kim, Carlo Brugnara, Barbara Degar, Jessica Pollard, Marian H Harris, Jacob R Bledsoe
Acute promyelocytic leukemia (APL) with variant RARA translocation is linked to over 15 partner genes. Recent publications encompassing six cases have expanded the spectrum of RARA partners to torque teno mini virus (TTMV). This entity is likely under-recognized due to lack of clinician and pathologist familiarity, inability to detect the fusion using routine testing modalities, and informatic challenges in its recognition within next-generation sequencing (NGS) data. We describe a clinicopathologic approach and provide necessary tools to screen and diagnose APL with TTMV::RARA using existing clinical DNA or RNA-based NGS assays, which led to identification of four cases, all without other known cytogenetic/molecular drivers...
May 2, 2024: Modern Pathology
https://read.qxmd.com/read/38702869/implant-survival-in-renal-transplanted-patients-a-prospective-long-term-study
#3
JOURNAL ARTICLE
Federico Berton, Matteo Zotti, Antonio Rapani, Fulvia Costantinides, Gaetano Castronovo, Roberto Di Lenarda, Claudio Stacchi
The present study aims to assess the feasibility of implant rehabilitation in kidney-transplanted patients. Patients with kidney transplantation included in periodontal supportive care and at least one year of dialysis with mono- or partial edentulism were eligible for this study. Histomorphometric evaluation of the harvested bone was matched with radiological bone assessment. Implant stability was also monitored with resonance frequency analysis and insertion torque value. Fixed cemented prostheses have been delivered after conventional loading protocol...
April 1, 2024: Journal of Oral Implantology
https://read.qxmd.com/read/38699598/pharmacological-p38-mapk-inhibitor-sb203580-enhances-aml-stem-cell-line-kg1a-chemosensitivity-to-daunorubicin-by-promoting-late-apoptosis-cell-growth-arrest-in-s-phase-and-mir-328-3p-upregulation
#4
JOURNAL ARTICLE
Sara Bahattab, Ali Assiri, Yazeid Alhaidan, Thadeo Trivilegio, Rehab AlRoshody, Sarah Huwaizi, Bader Almuzzaini, Abir Alamro, Manal Abudawood, Zeyad Alehaideb, Sabine Matou-Nasri
Acute myeloid leukaemia (AML) is characterized by uncontrolled proliferation of myeloid progenitor cells and impaired maturation, leading to immature cell accumulation in the bone marrow and bloodstream, resulting in hematopoietic dysfunction. Chemoresistance, hyperactivity of survival pathways, and miRNA alteration are major factors contributing to treatment failure and poor outcomes in AML patients. This study aimed to investigate the impact of the pharmacological p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580 on the chemoresistance potential of AML stem cell line KG1a to the therapeutic drug daunorubicin (DNR)...
June 2024: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38698080/treatment-of-newly-diagnosed-moderate-or-severe-chronic-graft-versus-host-disease-with-prednisone-and-everolimus-predever-first-a-prospective-multicenter-phase-iia-study
#5
JOURNAL ARTICLE
Francis Ayuk, Eva-Maria Wagner-Drouet, Daniel Wolff, Natascha von Huenerbein, Ute-Marie von Pein, Evgeny Klyuchnikov, Stephanie von Harsdorf, Christian Koenecke, Herbert Sayer, Nicolaus Kröger
Although most patients with chronic graft-versus-host disease (cGVHD) show initial response to first-line therapy, long-term clinically meaningful success of first-line treatment remains rare. In a prospective multicentre phase II trial in 6 German centers, patients with newly diagnosed moderate or severe cGVHD received prednisone and everolimus for 12 months followed by a 1-year follow-up period. Primary endpoint was treatment success (TS) at 6 months defined as patient being alive, achieving PR or CR of cGVHD, having no relapse of underlying disease and requiring no secondary treatment for cGVHD...
May 2, 2024: Bone Marrow Transplantation
https://read.qxmd.com/read/38697293/impact-of-early-cytomegalovirus-reactivation-after-allogeneic-hematopoietic-stem-cell-transplantation-on-relapse-in-patients-with-myelodysplastic-syndrome-a-nationwide-retrospective-study-from-adult-myelodysplastic-syndrome-working-group-of-the-jstct
#6
JOURNAL ARTICLE
Tatsuya Konishi, Kensuke Matsuda, Hidehiro Itonaga, Noriko Doki, Tetsuya Nishida, Ken-Ichi Matsuoka, Takashi Ikeda, Yoshinobu Kanda, Takahiro Fukuda, Junya Kanda, Hirohisa Nakamae, Kazunori Imada, Yasunori Ueda, Tatsuo Ichinohe, Yoshiko Atsuta, Ken Ishiyama
Cytomegalovirus (CMV) reactivation is a prominent complication associated with adverse outcomes in allogeneic hematopoietic stem cell transplantation (HSCT). However, CMV reactivation after allogeneic HSCT may be associated with a lower incidence of relapse in some hematological malignancies. This study analyzed the Japanese registry data from 1,082 patients with myelodysplastic syndrome (MDS) who underwent their first allogeneic HSCT and survived for 100 days after transplantation without graft failure or disease relapse to investigate this association...
April 30, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38694689/the-impact-of-bone-marrow-venting-augmentation-on-knee-functions-in-the-repair-of-vertical-longitudinal-meniscus-tears-a-triple-comparison
#7
JOURNAL ARTICLE
Ibrahim Halil Demir, Burcin Karslı
OBJECTIVE: Preserving and restoring meniscus function is crucial for maintaining knee biomechanics and overall functionality. To enhance the healing process after meniscus repair, various biological techniques have been introduced. In this study, three treatment approaches examined were bone marrow venting with stem cells (BMVP), anterior cruciate ligament reconstruction (ACLR) with meniscus repair, and isolated meniscus repair. MATERIALS AND METHODS: From 2015 to 2019, we retrospectively analyzed data from 83 patients who presented with complaints of knee pain or pain in addition to instability, were diagnosed with vertical/longitudinal meniscus tears, and underwent arthroscopic repair (30 with isolated repair, 28 with ACLR repair, and 25 with BMVP) at our University Hospital...
May 2024: Indian Journal of Orthopaedics
https://read.qxmd.com/read/38694497/combating-bone-marrow-failure-with-polymer-materials
#8
REVIEW
Kayla C Koch, Nidhi Jadon, Iris Thesmar, Gregory N Tew, Lisa M Minter
Bone marrow failure (BMF) has become one of the most studied autoimmune disorders, particularly due to its prevalence both as an inherited disease, but also as a result of chemotherapies. BMF is associated with severe symptoms such as bleeding episodes and susceptibility to infections, and often has underlying characteristics, such as anemia, thrombocytopenia, and neutropenia. The current treatment landscape for BMF requires stem cell transplantation or chemotherapies to induce immune suppression. However, there is limited donor cell availability or dose related toxicity associated with these treatments...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38693918/novel-anti-inflammatory-effects-of-the-il-1-receptor-in-kidney-myeloid-cells-following-ischemic-aki
#9
JOURNAL ARTICLE
Yanting Chen, Xiaohan Lu, Raeann L Whitney, Yu Li, Matthew J Robson, Randy D Blakely, Jen-Tsan Chi, Steven D Crowley, Jamie R Privratsky
Introduction: Acute kidney injury (AKI) is one of the most common causes of organ failure in critically ill patients. Following AKI, the canonical pro-inflammatory cytokine interleukin-1β (IL-1β) is released predominantly from activated myeloid cells and binds to the interleukin-1 receptor R1 (IL-1R1) on leukocytes and kidney parenchymal cells. IL-1R1 on kidney tubular cells is known to amplify the immune response and exacerbate AKI. However, the specific role of IL-1R1 on myeloid cells during AKI is poorly understood...
2024: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38687632/the-history-of-haploidentical-stem-cell-transplantation-a-trip-from-the-bench-to-the-bedside
#10
REVIEW
Mariana G Meade, Javier Bolaños-Meade
Allogeneic bone marrow transplantation is a curative intervention for both neoplastic and non-malignant conditions. However, not all patients have an HLA-matched donor. Therefore, the development of an approach that expand the donor pool was of paramount relevance. The development of post-transplantation cyclophosphamide as graft versus host disease prophylaxis allows the safe use of haploidentical donors, solving the donor availability problem to the vast majority of patients in need. The present paper reviews the history of the development of haploidentical transplantation at Johns Hopkins University, from the bench to the bedside...
December 2024: Hematology (Amsterdam, Netherlands)
https://read.qxmd.com/read/38687125/utility-of-blood-biomarkers-to-predict-marrow-iron-stores-in-children
#11
JOURNAL ARTICLE
Shilpa Sharma, Renata C Pereira, Elizabeta Nemeth, Mark R Hanudel, Joachim H Ix, Isidro B Salusky, Tomas Ganz
BACKGROUND: Iron deficiency is common in children with kidney failure, but current guidelines are based on biomarkers of iron stores that may be influenced by inflammation. This is the first study that examined which serum iron indices were associated with stainable marrow iron stores (the gold standard) in this population with kidney failure who underwent bone biopsies. METHODS: This cross-sectional study enrolled 71 clinically stable children and young adults receiving dialysis who underwent bone biopsy for chronic kidney disease-mineral bone disorder between 2007 through 2011...
April 30, 2024: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/38684435/-pathogenesis-of-myelodysplastic-syndromes-by-excessive-mitochondrial-fragmentation
#12
JOURNAL ARTICLE
Yoshihiro Hayashi
Myelodysplastic syndromes (MDS) are a group of heterogenous hematopoietic stem cell (HSC) malignancies characterized by ineffective hematopoiesis in which clonal progenitor expansion occurs alongside impaired myelopoiesis. Inflammatory signaling activation due to dysregulated innate immunity is also a hallmark of MDS pathogenesis. We recently established a useful preclinical tool that recapitulates bona fide MDS phenotypes and gene expression profiles based on previously unreported co-mutations discovered during our clinical surveillance of mutations in patients with MDS...
2024: [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology
https://read.qxmd.com/read/38682429/a-naturally-occurring-canine-model-of-syndromic-congenital-microphthalmia
#13
JOURNAL ARTICLE
Leonardo Murgiano, Esha Banjeree, Cynthia O'Connor, Keiko Miyadera, Petra Werner, Jessica K Niggel, Gustavo D Aguirre, Margret L Casal
In humans, the prevalence of congenital microphthalmia is estimated to be 0.2-3.0 for every 10,000 individuals, with nonocular involvement reported in ∼80% of cases. Inherited eye diseases have been widely and descriptively characterized in dogs, and canine models of ocular diseases have played an essential role in unraveling the pathophysiology and development of new therapies. A naturally occurring canine model of a syndromic disorder characterized by microphthalmia was discovered in the Portuguese water dog...
April 29, 2024: G3: Genes—Genomes—Genetics
https://read.qxmd.com/read/38679747/thrombopoietin-mimetic-stimulates-bone-marrow-vascular-and-stromal-niches-to-mitigate-acute-radiation-syndrome
#14
JOURNAL ARTICLE
Justin Vercellino, Beata Małachowska, Shilpa Kulkarni, Brett I Bell, Shahin Shajahan, Kosaku Shinoda, Gary Eichenbaum, Amit K Verma, Sanchita P Ghosh, Weng-Lang Yang, Paul S Frenette, Chandan Guha
BACKGROUND: Acute radiation syndrome (ARS) manifests after exposure to high doses of radiation in the instances of radiologic accidents or incidents. Facilitating regeneration of the bone marrow (BM), namely the hematopoietic stem and progenitor cells (HSPCs), is key in mitigating ARS and multi-organ failure. JNJ-26366821, a PEGylated thrombopoietin mimetic (TPOm) peptide, has been shown as an effective medical countermeasure (MCM) to treat hematopoietic-ARS (H-ARS) in mice. However, the activity of TPOm on regulating BM vascular and stromal niches to support HSPC regeneration has yet to be elucidated...
April 29, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38675960/mesenchymal-stem-cell-derived-exosomes-attenuate-murine-cytomegalovirus-infected-pneumonia-via-nf-%C3%AE%C2%BAb-nlrp3-signaling-pathway
#15
JOURNAL ARTICLE
Fei Chen, Zhida Chen, Hui-Ting Wu, Xin-Xiang Chen, Peiqi Zhan, Zheng-Yi Wei, Zizhang Ouyang, Xueyan Jiang, Ao Shen, Min-Hua Luo, Qifa Liu, Yue-Peng Zhou, Aiping Qin
Reactivation and infection with cytomegalovirus (CMV) are frequently observed in recipients of solid organ transplants, bone marrow transplants, and individuals with HIV infection. This presents an increasing risk of allograft rejection, opportunistic infection, graft failure, and patient mortality. Among immunocompromised hosts, interstitial pneumonia is the most critical clinical manifestation of CMV infection. Recent studies have demonstrated the potential therapeutic benefits of exosomes derived from mesenchymal stem cells (MSC-exos) in preclinical models of acute lung injury, including pneumonia, ARDS, and sepsis...
April 16, 2024: Viruses
https://read.qxmd.com/read/38669341/modified-delphi-panel-consensus-recommendations-for-management-of-severe-aplastic-anemia
#16
JOURNAL ARTICLE
Daria V Babushok, Amy E DeZern, Carlos de Castro, Zora R Rogers, David Beenhouwer, Michael S Broder, Suzanne Fanning, Sarah N Gibbs, Rabi Hanna, Jaroslaw P Maciejewski, Bart L Scott, Srinivas K Tantravahi, Marcin W Wlodarski, Irina Yermilov, Bhumika J Patel
Severe aplastic anemia (SAA) is a rare hematologic condition for which there is no clear management algorithm. A panel of 11 adult and pediatric experts on aplastic anemia was assembled and, using the RAND/UCLA modified Delphi panel method, evaluated >600 varying patient care scenarios to develop clinical recommendations for the initial and subsequent management of patients of all ages with SAA. Here we present the panel's recommendations to rule out inherited bone marrow failure (IBMF) syndromes, on supportive care prior to and during first-line therapy, and on first-line (initial management) and second-line (subsequent management) therapy of acquired SAA, focusing on when transplant versus medical therapy is most appropriate...
April 26, 2024: Blood Advances
https://read.qxmd.com/read/38666363/iguratimod-prevents-renal-fibrosis-in-unilateral-ureteral-obstruction-model-mice-by-suppressing-m2-macrophage-infiltration-and-macrophage-myofibroblast-transition
#17
JOURNAL ARTICLE
Yueyuan Zhou, Zhilan Li, Shenyi Yu, Xuan Wang, Tingting Xie, Weiru Zhang
Iguratimod is a novel synthetic, small-molecule immunosuppressive agent used to treat rheumatoid arthritis. Through ongoing exploration of its role and mechanisms of action, iguratimod has been observed to have antifibrotic effects in the lung and skin; however, its effect on renal fibrosis remains unknown. This study aimed to investigate whether iguratimod could affect renal fibrosis progression. Three different concentrations of iguratimod (30 mg/kg/day, 10 mg/kg/day, and 3 mg/kg/day) were used to intervene in unilateral ureteral obstruction (UUO) model mice...
December 2024: Renal Failure
https://read.qxmd.com/read/38665754/cyclophosphamide-bortezomib-and-dexamethasone-and-severe-systolic-heart-failure-a-case-report
#18
Sagar Pandey, Ernestine Faye S Tan, Amulya Bellamkonda, Binit Aryal, Madhumati Kalavar
Multiple myeloma (MM) is a neoplastic proliferation of plasma cells in bone marrow. Pharmacotherapy for the management of patients with MM includes drug classes like proteasome inhibitors, monoclonal antibodies, immunomodulators, alkylating agents, steroids, etc. We present a case of new-onset heart failure with reduced ejection fraction (HFrEF) in a patient with previously normal ejection fraction after treatment with a cyclophosphamide, bortezomib, and dexamethasone (CyBorD) chemotherapeutic regimen. An echocardiogram done after the completion of nine cycles of chemotherapy in a period of about 4...
March 2024: Curēus
https://read.qxmd.com/read/38658784/pediatric-acute-promyelocytic-leukemia-and-fanconi-anemia-case-report-and-literature-review
#19
JOURNAL ARTICLE
Claire Freycon, Edith Sepulchre, Vincent-Philippe Lavallée, David Mitchell, Margaret L MacMillan, Catherine Vezina, Catherine Goudie
Acute promyelocytic leukemia (APL) represents 5%-10% of childhood acute myeloid leukemia (AML) and is the most curable subtype of AML. Fanconi anemia (FA) is one of the most common inherited bone marrow failure syndromes caused by biallelic pathogenic variants (PV) in specific DNA-repair genes. Biallelic PVs in FANCD1/BRCA2 (FA-D1) account for 3% of FA and are associated with early-onset leukemia and a high risk of solid tumors. We report a 4 year-old boy from non-consanguineous parents diagnosed with standard risk APL...
April 24, 2024: Clinical Genetics
https://read.qxmd.com/read/38655920/effect-of-experimental-pulmonary-arterial-hypertension-on-renal-and-bone-parameters-of-rats-submitted-to-resistance-exercise-training
#20
JOURNAL ARTICLE
Leôncio L Soares, Luciano B Leite, Maíra O Freitas, Luiz Otávio G Ervilha, Mayra S Píccolo, Alexandre M O Portes, Filipe R Drummond, Leonardo Mateus T DE Rezende, Mariana M Neves, Emily C C Reis, Miguel A Carneiro-Júnior, Antônio José Natali
Pulmonary arterial hypertension (PAH) is characterized by right ventricular failure and diminished cardiac output, potentially leading to renal and bone impairments. In contrast, resistance exercise training (RT) offers cardiovascular and bone health benefits. This study aimed to assess the impacts of stable PAH induced by monocrotaline (MCT) and RT on renal morphometry, as well as bone morphometry and biomechanical properties in male Wistar rats. Four experimental groups, untrained control (UC, n=7), trained control (TC, n=7), untrained hypertensive (UH, n=7), trained hypertensive (TH, n=7), were defined...
2024: Anais da Academia Brasileira de Ciências
keyword
keyword
8492
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.